메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
Jong Man Kim (Sungkyunkwan University) Kwang-Woong Lee (Seoul National University) Gi-Won Song (University of Ulsan) Bo-Hyun Jung (Seoul National University) Hae Won Lee (Seoul Metropolitan Government-Seoul National University Boramae Medical Center) Nam-Joon Yi (Seoul National University) Choon Hyuck David Kwon (Sungkyunkwan University) Shin Hwang (University of Ulsan) Kyung-Suk Suh (Seoul National University) Jae-Won Joh (Sungkyunkwan University) Suk-Koo Lee (Sungkyunkwan University) Sung-Gyu Lee (University of Ulsan)
저널정보
대한외과학회 Annals of Surgical Treatment and Research Annals of Surgical Treatment and Research Vol.90 No.1
발행연도
2015.12
수록면
36 - 42 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
Purpose: HCV-related liver disease is the most common indication for liver transplantation (LT) in Western countries, whereas HCV LT is rare in Korea. We conducted a survey of HCV RNA-positive patients who underwent LT and investigated the prognostic factors for patient survival and the effects of immunosuppression.
Methods: We retrospectively reviewed the multicenter records of 192 HCV RNA-positive patients who underwent LT.
Results: The 1-, 3-, and 5-year overall survival rates were 78.8%, 75.3%, and 73.1%, respectively. Excluding the cases of hospital mortality (n = 23), 169 patients were evaluated for patient survival. Most patients were genotype 1 (n = 111, 65.7%) or genotype 2 (n = 42, 24.9%). The proportion of living donors for LT (n = 135, 79.9%) was higher than that of deceased donors (deceased donor liver transplantation [DDLT], n = 34, 20.1%). The median donor and recipient ages were 32 years and 56 years, respectively. Twenty-eight patients (16.6%) died during the observation period. Seventy-five patients underwent universal prophylaxis and 15 received preemptive therapy. HCV recurrence was detected in 97 patients.Recipients who were older than 60, received DDLT, used cyclosporine, or suffered acute rejection had lower rates of survival.
Conclusion: Patent survival rates of HCV patients after LT in Korea were comparable with other countries.

목차

INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

이 논문과 함께 이용한 논문

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2016-514-002399304